Responses
Regular and young investigator award abstracts
Immunotherapy toxicities
637 Immune-related adverse events (irAEs) may indicate a favorable prognosis in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)
Compose a Response to This Article
Other responses
No responses have been published for this article.